Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy

PURPOSE: Few data are available concerning the clinical outcome of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in terms of the duration of androgen deprivation therapy (ADT) before diagnosis of CRPC. We investigated the clinical efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ki Bom, Jo, Jung Ki, Ahn, Soyeon, Lee, Sangchul, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok-Soo, Lee, Sang Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534432/
https://www.ncbi.nlm.nih.gov/pubmed/26279827
http://dx.doi.org/10.4111/kju.2015.56.8.580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534432/
https://www.ncbi.nlm.nih.gov/pubmed/26279827
http://dx.doi.org/10.4111/kju.2015.56.8.580

Ejemplares similares